ATP6V1G2 and central nervous system cancer: The results implied that advanced age, high-grade tumor, 1p/19q non-codeletion, IDH-non mutation, low expression of ATP6V1G2, GABARAPL1 and GOT1 might be poor prognostic factors for glioma patients.